TR200907237A2 - Tiotropyum kuru toz kombinasyonu - Google Patents

Tiotropyum kuru toz kombinasyonu

Info

Publication number
TR200907237A2
TR200907237A2 TR2009/07237A TR200907237A TR200907237A2 TR 200907237 A2 TR200907237 A2 TR 200907237A2 TR 2009/07237 A TR2009/07237 A TR 2009/07237A TR 200907237 A TR200907237 A TR 200907237A TR 200907237 A2 TR200907237 A2 TR 200907237A2
Authority
TR
Turkey
Prior art keywords
dry powder
powder combination
tiotropium
tiotropium dry
combination
Prior art date
Application number
TR2009/07237A
Other languages
English (en)
Inventor
B�Lg�� Mahmut
Original Assignee
B�Lg�� Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B�Lg�� Mahmut filed Critical B�Lg�� Mahmut
Priority to TR2009/07237A priority Critical patent/TR200907237A2/tr
Priority to EP10787588A priority patent/EP2480287A2/en
Priority to PCT/TR2010/000184 priority patent/WO2011037550A2/en
Publication of TR200907237A2 publication Critical patent/TR200907237A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, solunum yolları rahatsızlıklarında kullanılmak üzere, tiotropium aktif maddesinin etkili miktarlardaki kromolin türevi bir madde ile birlikte formüle edildiği inhalasyon yoluyla kullanılacak bir ilaç bileşimine dairdir.
TR2009/07237A 2009-09-23 2009-09-23 Tiotropyum kuru toz kombinasyonu TR200907237A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2009/07237A TR200907237A2 (tr) 2009-09-23 2009-09-23 Tiotropyum kuru toz kombinasyonu
EP10787588A EP2480287A2 (en) 2009-09-23 2010-09-22 Dry powder combination of tiotropium
PCT/TR2010/000184 WO2011037550A2 (en) 2009-09-23 2010-09-22 Dry powder combination of tiotropium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/07237A TR200907237A2 (tr) 2009-09-23 2009-09-23 Tiotropyum kuru toz kombinasyonu

Publications (1)

Publication Number Publication Date
TR200907237A2 true TR200907237A2 (tr) 2011-04-21

Family

ID=43643869

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/07237A TR200907237A2 (tr) 2009-09-23 2009-09-23 Tiotropyum kuru toz kombinasyonu

Country Status (3)

Country Link
EP (1) EP2480287A2 (tr)
TR (1) TR200907237A2 (tr)
WO (1) WO2011037550A2 (tr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712251D0 (en) * 1987-05-23 1987-07-01 Fisons Plc Formulation
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
GB9006233D0 (en) 1990-03-20 1990-05-16 Kenrick & Jefferson Ltd Forms,for use,for example,as parking tickets
CN1150890C (zh) * 1998-08-04 2004-05-26 杰格研究股份公司 药用气溶胶制剂
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
HUP0301377A3 (en) * 2000-10-31 2005-12-28 Boehringer Ingelheim Pharma Combination pharmaceutical composition in form of inhalative solution containing a tiotropium salt
WO2006076222A2 (en) * 2005-01-10 2006-07-20 Glaxo Group Limited Pharmaceutical formulations

Also Published As

Publication number Publication date
WO2011037550A3 (en) 2011-09-15
WO2011037550A2 (en) 2011-03-31
EP2480287A2 (en) 2012-08-01

Similar Documents

Publication Publication Date Title
SV2009003236A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hematologicas
EA201291306A1 (ru) Состав сухого порошка, содержащий антимускариновое средство
ECSP13012612A (es) Derivados de quinazolin-4-(3h)-ona utilizados como inhibidores de p13 cinasa
MX2011011733A (es) Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos.
HN2010001920A (es) Dihidropirazolonas sustituidas como inhibidores de hif- propil-4-hidroxilasa
MX360554B (es) Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2.
TR201008226A2 (tr) Kapsül içeren bir inhalasyon cihazı.
CU20100111A7 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso para el tratamiento y prevención de enfermedades pulmonares y cardiovasculares
TR200803522A1 (tr) Kolay kullanımlı inhalasyon cihazı.
CU20130072A7 (es) 1 h-pirazol-5-olato sódico sustituido
TR201000733A2 (tr) Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
MX378056B (es) Composiciones de cuidado oral.
BRPI1005932A2 (pt) composto, composição farmacêutica para inalação e inalador
TR200907917A2 (tr) Kuru toz inhaleri.
PH12016500577B1 (en) Piperazine derivatives and the use thereof as medicament
TR201205852A2 (tr) Geliştirilmiş yeni kuru toz formülasyonu.
TR200909792A2 (tr) Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
TR200907237A2 (tr) Tiotropyum kuru toz kombinasyonu
TR200803525A2 (tr) Toz ilaç soluma cihazı.
TR200909790A2 (tr) Tiotropyum, formoterol ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
TR201105367A2 (tr) Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
TR200909789A2 (tr) Tiotropyum, budesonid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
TR200909788A2 (tr) Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
TR200909793A2 (tr) Tiotropyum, mometazon ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
TR201007251A2 (tr) Kalsiyum kanal blokörü formülasyonu.